by Jordana Choucair | Jul 7, 2022 | Life Sciences
Senate Democrats narrowly reached a deal on drug pricing reforms, which includes granting Medicare the power to negotiate prices for certain drugs. According to text released Wednesday, the U.S. Department of Health and Human Services (HHS) will choose 10 drugs...
by Jordana Choucair | Jul 7, 2022 | Life Sciences
The Food and Drug Administration (FDA) said state-licensed pharmacists can prescribe Pfizer Inc.’s COVID-19 antiviral pill Paxlovid to eligible patients. Pharmacists will be subject to some parameters around prescribing, and the FDA said people who test positive...
by Jordana Choucair | Jul 7, 2022 | Life Sciences
The FDA announced it will develop a new framework to help overseas baby formula manufacturers market their products in the U.S. after the formula shortage eases. The FDA would offer technical assistance to companies seeking to enter the U.S. market and issue...
by Jordana Choucair | Jul 6, 2022 | Life Sciences
The Food and Drug Administration (FDA) announced it has temporarily suspended its ban on sales of the e-cigarette maker Juul. The agency also said that the company is allowed to market its products in the U.S. for the time being. The announcement comes two weeks after...
by Jordana Choucair | Jul 5, 2022 | Life Sciences
Pfizer’s success in developing COVID-19 vaccines and medicines has not only helped the company yield record revenue but has also given the drugmaker unusual weight in determining U.S. health policy. Based on internal research conducted by Kaiser Health News, the...
by Jordana Choucair | Jul 1, 2022 | Life Sciences
Senate Democrats plan to submit a revised proposal to lower prescription drug prices for a key procedural review in the coming days as they press forward with preparations for a vote on Biden’s economic package. The plan would allow Medicare to negotiate lower prices...
Recent Comments